Home › Companies › Bioventus Inc.

Bioventus Inc. (BVS) proxy voting records

How asset managers voted at Bioventus Inc.’s shareholder meetings, one page per proxy season, compiled from the votes funds and managers report on SEC Form N-PX and the company’s own results on Form 8-K.

TickerBVS
CUSIP issuer number09075A
SEC CIK1665988

Recent shareholder votes

June 3, 2026 annual meeting (2025-2026 proxy season): 12 items in Bioventus Inc.'s official results (Form 8-K, filed June 4, 2026); lowest support 90% of votes cast (Elect Director: Martin P. Sutter). Full results and how funds voted.
June 3, 2025 annual meeting (2024-2025 proxy season): 6 items in Bioventus Inc.'s official results (Form 8-K, filed June 4, 2025); lowest support 89% of votes cast (Elect Director: Martin P. Sutter). Full results and how funds voted.

Each line is the company’s own Form 8-K tally as shown on that season’s page; support is FOR as a share of votes cast.

Proxy seasons

Season	Filed as	Ballot items	Asset managers
2025-2026	Bioventus Inc.	13	53
2024-2025	Bioventus Inc.	7	53

Explore Bioventus Inc. in the interactive database

The seasons are grouped by the issuer number in the company’s CUSIP, not by its name. Ticker as listed by the SEC on November 6, 2026. This page is rebuilt weekly; built November 9, 2026.